July 26, 2021
2 min watch
Save
VIDEO: Dexycu effective in real-world trial
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Mitchell A. Jackson, MD, discusses his practice’s experience participating in a real-world study investigating Dexycu (dexamethasone intraocular suspension 9%, EyePoint).
Published by:
Sources/Disclosures
Collapse
Source:
Mitchell A. Jackson, MD
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.